Dr Reddy’s Moves Ahead With Global Rituximab Filings

US FDA, EMA And MHRA Accept Firm’s Rituxan/MabThera Biosimilar Rival For Review

 
• By Dave Wallace
  
Dr Reddy's logo on website under magnifying glass
Dr Reddy’s has filed rituximab with multiple regulators • Source: Shutterstock

More from Biosimilars

More from Products